Highly and Widely Effective, Water Stable, and Non Toxic Titanium-Phenolato-based Anticancer Chemotherapy

Project Information

safenolaTiCancerDrug

Grant agreement ID: 779689

DOI

10.3030/779689

Project closed

EC signature date 18 October 2017

Start date 1 November 2017

End date 30 April 2019

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 150 000,00

EU contribution

€ 150 000,00

Coordinated by

THE HEBREW UNIVERSITY OF JERUSALEM
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

In Vivo AnticancerActivityof aNontoxicInertPhenolatoTitaniumComplex:High Efficacyon SolidTumorsAloneand CombinedwithPlatinumDrugs

Author(s): Nitzan Ganot, Ori Braitbard, Asaad Gammal, Joseph Tam, Jacob Hochman, Edit Y. Tshuva
Published in: ChemMedChem, 2018, ISSN 1860-7187
Publisher: WILEY-VCH
DOI: 10.1002/cmdc.201800551